These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4270680)

  • 21. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia].
    Ranklev-Twetman E; Isander G; Fletcher R
    Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048
    [No Abstract]   [Full Text] [Related]  

  • 22. [Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl)].
    Shimonaka H; Yamamoto M
    Masui; 1981 Feb; 30(2):141-9. PubMed ID: 7277676
    [No Abstract]   [Full Text] [Related]  

  • 23. A hypermetabolic reaction during anaesthesia and surgery. A case report.
    Hopkins D; Shipton EA
    S Afr J Surg; 1993 Jun; 31(2):85-8. PubMed ID: 8211415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia.
    Harrison GG
    Anaesthesist; 1973 Aug; 22(8):373-6. PubMed ID: 4749220
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biochemical and electromyographic studies on a family with malignant hyperpyrexia].
    Konno K; Yamashiro H; Hagiwara M; Haseba J; Honda N
    Masui; 1974 Sep; 23(9):854-61. PubMed ID: 4475138
    [No Abstract]   [Full Text] [Related]  

  • 26. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)].
    Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S
    Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)].
    Morikawa S; Murata M; Murata H; Iwai S
    Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant hyperthermia.
    Nasir KK; Zafar AB; Mansoor F; Mushtaq S; Ahmad J; Khan IM
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):39-40. PubMed ID: 14764260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological and neuropharmacological aspects of malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):66-7. PubMed ID: 4690061
    [No Abstract]   [Full Text] [Related]  

  • 30. [Malignant hypothermia, 3 cases (author's transl)].
    Utke G; Quos A; Wegener R
    Zentralbl Chir; 1980; 105(23):1573-82. PubMed ID: 7211003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)].
    Plötz J
    Anaesthesist; 1980 Feb; 29(2):94-8. PubMed ID: 7377529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anesthesia for a patient with eosinophilic myositis.
    Farag HM; Naguib M; Gyasi H; Ibrahim AW
    Anesth Analg; 1986 Aug; 65(8):903-4. PubMed ID: 2942057
    [No Abstract]   [Full Text] [Related]  

  • 33. Histochemical abnormalities of muscle in malignant hyperpyrexia (MH).
    Schiller HH
    Z Neurol; 1973 Feb; 203(4):265-9. PubMed ID: 4120792
    [No Abstract]   [Full Text] [Related]  

  • 34. Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia.
    Malandrini A; Orrico A; Gaudiano C; Gambelli S; Galli L; Berti G; Tegazzin V; Dotti MT; Federico A; Sorrentino V
    Anesthesiology; 2008 Oct; 109(4):625-8. PubMed ID: 18813041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction.
    Kratholm S; Nielsen E
    Anaesth Resusc Intensive Ther; 1974; 2(4):359-63. PubMed ID: 4460754
    [No Abstract]   [Full Text] [Related]  

  • 36. ["Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl)].
    Malz H; Gullotta F; Klein H; Aebert K
    Anaesthesist; 1982 May; 31(5):248-51. PubMed ID: 7103033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eulenburg's paramyotonia: clinical, histological, histochemical, ultrastructural and genetic aspects (presentation of 4 cases)].
    Giacanelli M; Massi G; Tarquini D
    Riv Neurobiol; 1979; 25(2):178-92. PubMed ID: 554343
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.
    Britt BA
    N Engl J Med; 1974 May; 290(20):1140-2. PubMed ID: 4274465
    [No Abstract]   [Full Text] [Related]  

  • 39. Type 2B muscle fibre deficiency in myotonia and paramyotonia congenita. A genetically determined histochemical fibre type pattern?
    Heene R; Gabriel RR; Manz F; Schimrigk K
    J Neurol Sci; 1986 Mar; 73(1):23-30. PubMed ID: 2939200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant hyperthermia, chronic alcoholism and tubular aggregates (author's transl)].
    Gullotta F; Wierich W; Dieckmann J
    Prakt Anaesth; 1976 Dec; 11(6):410-5. PubMed ID: 1013054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.